↓ Skip to main content

18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model

Overview of attention for article published in Frontiers in Medicine, October 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model
Published in
Frontiers in Medicine, October 2022
DOI 10.3389/fmed.2022.992993
Pubmed ID
Authors

Laura M. Bartos, Sabrina V. Kirchleitner, Jens Blobner, Karin Wind, Lea H. Kunze, Adrien Holzgreve, Lukas Gold, Artem Zatcepin, Zeynep Ilgin Kolabas, Selin Ulukaya, Lorraine Weidner, Stefanie Quach, Denise Messerer, Peter Bartenstein, Joerg C. Tonn, Markus J. Riemenschneider, Sibylle Ziegler, Louisa von Baumgarten, Nathalie L. Albert, Matthias Brendel

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 67%
Student > Master 1 33%
Readers by discipline Count As %
Neuroscience 2 67%
Pharmacology, Toxicology and Pharmaceutical Science 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#15,651,993
of 24,792,414 outputs
Outputs from Frontiers in Medicine
#2,979
of 6,844 outputs
Outputs of similar age
#214,896
of 435,457 outputs
Outputs of similar age from Frontiers in Medicine
#212
of 506 outputs
Altmetric has tracked 24,792,414 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,844 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,457 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 506 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.